Recent News

• 02.05.2026 - Rhythm Pharmaceuticals Announces Participation in Upcoming Guggenheim Biotech Summit
• 01.09.2026 - Rhythm Pharmaceuticals Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Product Revenues and Upcoming Milestones
• 12.11.2025 - Rhythm Pharmaceuticals Announces Preliminary Data from Exploratory Phase 2 Trial that showed Setmelanotide Demonstrated Positive Efficacy Signal in Prader-Willi Syndrome

Recent Filings

• 02.05.2026 - 144 Report of proposed sale of securities
• 02.04.2026 - 144 Report of proposed sale of securities
• 02.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.03.2026 - 4 Statement of changes in beneficial ownership of securities